Susanna High

Susanna High

Algemeen Directeur bij
Paragon Therapeutics, Inc.
58 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Susanna G.
High
is currently the Chief Executive Officer at Paragon Therapeutics, Inc. She previously held positions as the Director-Corporate Strategy at Millennium Pharmaceuticals, Inc. from 2001 to 2007, the Chief Operating Officer at bluebird bio, Inc. from 2016 to 2019, and the SVP-Strategy & Business Integration at Alnylam Pharmaceuticals, Inc. from 2007 to 2016.
Prior to that, she worked as a Management Consultant at Accenture LLC from 1996 to 2001.
Ms. High also served as the Chief Operating Officer at Dyne Therapeutics, Inc. from 2020 to 2024.
She graduated from the University of Bocconi and holds an MBA from MIT Sloan School of Management, which she received in 1996.

Actieve functies van Susanna High

BedrijvenFunctieBegin
Algemeen Directeur 21-11-2024

Eerdere bekende functies van Susanna High

BedrijvenFunctieEinde
DYNE THERAPEUTICS, INC. Operationeel Directeur 01-10-2024
GENETIX BIOTHERAPEUTICS, INC. Operationeel Directeur 04-01-2019
ALNYLAM PHARMACEUTICALS, INC. Directeur/Bestuurslid 01-06-2008
Corporate Officer/Principal 01-01-2007
Corporate Officer/Principal 01-01-2001
Ervaring van Susanna High in detail bekijken

Opleiding van Susanna High

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

82

Eerstegraads connecties

8

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit8

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Health Technology

Commercial Services

  1. Beurs
  2. Insiders
  3. Susanna High